KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Treasury Shares (2017 - 2025)

Historic Treasury Shares for TherapeuticsMD (TXMD) over the last 10 years, with Q1 2025 value amounting to $5000.0.

  • TherapeuticsMD's Treasury Shares rose 1305789.47% to $5000.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $5000.0, marking a year-over-year increase of 1305789.47%. This contributed to the annual value of $5000.0 for FY2024, which is 8750.0% down from last year.
  • Per TherapeuticsMD's latest filing, its Treasury Shares stood at $5000.0 for Q1 2025, which was up 1305789.47% from $5000.0 recorded in Q4 2024.
  • In the past 5 years, TherapeuticsMD's Treasury Shares ranged from a high of $16.1 million in Q3 2021 and a low of $38.0 during Q1 2024
  • Its 5-year average for Treasury Shares is $1.4 million, with a median of $84000.0 in 2023.
  • In the last 5 years, TherapeuticsMD's Treasury Shares skyrocketed by 2085588.24% in 2022 and then tumbled by 9997.85% in 2024.
  • Quarter analysis of 5 years shows TherapeuticsMD's Treasury Shares stood at $272.0 in 2021, then surged by 20855.88% to $57000.0 in 2022, then fell by 29.82% to $40000.0 in 2023, then crashed by 87.5% to $5000.0 in 2024, then changed by 0.0% to $5000.0 in 2025.
  • Its Treasury Shares was $5000.0 in Q1 2025, compared to $5000.0 in Q4 2024 and $5000.0 in Q3 2024.